Marinomed Biotech AG

Major Shareholding Notification • Feb 5, 2019

Publication Date: 05.02.2019 16:47 EANS-Voting Rights: Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act

Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018 Wien, 4.2.2019 Overview 1. Issuer: Marinomed Biotech AG 2. Reason for the notification: Acquisition or disposal of voting rights Other 3. Person subject to notification obligation

Acting in concert (Sec. 133 No. 7 BörseG 2018)

	________________
	Firstname _Name/Surname _City___ Country
	Abdulmohsen__ Al_Sheikh_ ___ _____
	Mohammed___ Al_Sheikh__ ___ ______
	Acropora Beteiligungs Wien	Österreich
	__ GmbH__ ___ __

1. Name of shareholder(s):

2. Date on which the threshold was crossed or reached: 1.2.2019

3. Total positions

____________
		% of voting
	% of voting			rights through Total of both Total number of
		rights attached financial/other in % (7.A +		voting rights
	to shares (7.A) instruments		7.B)	of issuer
__ _______________ (7.B.1+7.B.2) __ __
Resulting
situation on
the date on	26,42 %	0,00 %	26,42 %	1 260 000
which threshold
was crossed /
_reached __ __ __ __
Position of
previous
notification
(if_applicable) __ __ __ ___

Details

1. Notified details of the resulting situation:

				____________
A:Voting_rights_attached_to_shares______
			_Numberof_voting_rights _______%of_voting_rights____
	Direct Indirect		Direct	Indirect
ISIN Code				(Sec 130 BörseG (Sec 133 BörseG (Sec 130 BörseG (Sec 133 BörseG
				___ 2018)__ _2018) __2018)_ 2018)___
				ATMARINOMED6_ _332_910 _______________ ________26,42% ____
				SUBTOTAL_A__ ____________332_910____________ ____________26,42%_______

|B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG | |2018__________________________________________________________________________| | | | |Number of voting | |

______________________________________________________________________________

		rights that may
Type of		be % of voting
instrument	Expiration Date Exercise Period acquired if the	rights
		instrument is
		___ ___ ___ __exercised_ _____
		___ ___ _SUBTOTAL_B.1 __ _____

	___________
	B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG
	2018_____________
Type of	Expiration Exercise		Physical /	Number of		% of voting
instrument	Date	Period	Cash	voting rights		rights
	__ _ ___________ Settlement__ ____ ______
	__ _ __ SUBTOTALB.2_ __ _

1. Information in relation to the person subject to the notification obligation: Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:

	___________			Financial/
		Directly	Shares held	other	Total of both
No.	Name		controlled directly (%) instruments		(%)
		by No.		held directly
	_ _ __ _ (%)_ _____
1	Abdulmohsen
	_ AlSheikh_ __ _ _ ____
2	Mohammed Al
	_ Sheikh __ ___ __ ____
	Acropora
3	Beteiligungs	1,2	26,42 %		26,42 %
	_ GmbH_ ___ ___ __ ____

1. In case of proxy voting Date of general meeting: - Voting rights after general meeting: - is equivalent to - voting rights. 10. Sonstige Kommentare: Die Beteiligungsmeldung erfolgt aufgrund der erstmaligen Zulassung gem § 130 Abs 7 BörseG 2018. Wien am 4.2.2019

end of announcement euro adhoc --------------------------------------------------------------------------------

issuer:	Marinomed Biotech AG
	Veterinärplatz 1
	A-1210 Wien
phone:	0043250774460
FAX:	0043250774493
mail:	office@marinomed.com
WWW:	www.marinomed.com
ISIN:	ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language:	English